Unprecedented Demand
Once-unfathomable breakthroughs in genome sequencing have fundamentally altered the trajectory of the Life Sciences industry, while also changing the course of human history in the process.
The commercialization of DNA sequencing and genetic-based therapies have created increased demand for research and development (R&D), laboratory, and bio-manufacturing space. The United States is actively onshoring all of this work, intensifying the need for Life Sciences real estate in the process.
BioChain Real Assets is actively working to make space for this innovation.
Value-Driven Investing
Our firm selects markets where there is a disconnect between land value and current demand. We specialize on creating profit on the acquisition of the land and being an early mover in our given markets. We then pass profitability to our partners through a detailed and collaborative development process; delivering to the market the most advanced and adaptable buildings in the industry.